Obesity and statins are both independent predictors of enhanced coronary arteriolar dilation in patients undergoing heart surgery

Journal of Cardiothoracic Surgery

Volumn 8, Issue 1, 2013, Pages

  Cassuto, James ^a   Feher, Attila ^a   Lan, Ling ^a   Patel, Vijay S ^a   Kamath, Vinayak ^a   Anthony, Daniel C ^b   Bagi, Zsolt ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Coronary arteriole; Microcirculation; Obesity paradox; Statin

Indexed keywords

BRADYKININ; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; BODY MASS; COMPLICATION; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DRUG EFFECTS; FEMALE; HEART SURGERY; HUMAN; IN VITRO STUDY; MALE; MICROCIRCULATION; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; REGRESSION ANALYSIS; RISK FACTOR; VASODILATATION; VIDEO MICROSCOPY;

AGED; BODY MASS INDEX; BRADYKININ; CARDIAC SURGICAL PROCEDURES; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IN VITRO TECHNIQUES; MALE; MICROCIRCULATION; MICROSCOPY, VIDEO; MIDDLE AGED; OBESITY; REGRESSION ANALYSIS; RISK FACTORS; VASODILATION;

EID: 84876806568     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-8-117     Document Type: Article

References (27)

1. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006, 355:763-778. 10.1056/NEJMoa055643, 16926275.
2. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009, 53:1925-1932. 10.1016/j.jacc.2008.12.068, 19460605.
3. Krauss R, Winston M, Fletcher B, Grundy S. Obesity : impact on cardiovascular disease. Circulation 1998, 98:1472-1476. 10.1161/01.CIR.98.14.1472, 9760304.
4. Martin JW, Briesmiester K, Bargardi A, Muzik O, Mosca L, Duvernoy CS. Weight changes and obesity predict impaired resting and endothelium-dependent myocardial blood flow in postmenopausal women. Clin Cardiol 2005, 28:13-18. 10.1002/clc.4960280105, 15704526.
5. Motivala AA, Rose PA, Kim HM, Smith YR, Bartnik C, Brook RD, Muzik O, Duvernoy CS. Cardiovascular risk, obesity, and myocardial blood flow in postmenopausal women. Journal of nuclear cardiology: official publication of the American Society of Nuclear Cardiology 2008, 15:510-517.
6. Schindler TH, Cardenas J, Prior JO, Facta AD, Kreissl MC, Zhang X-L, Sayre J, Dahlbom M, Licinio J, Schelbert HR. Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function. J Am Coll Cardiol 2006, 47:1188-1195. 10.1016/j.jacc.2005.10.062, 16545651.
7. Wang L, Jerosch-Herold M, Jacobs DR, Shahar E, Folsom AR. Coronary risk factors and myocardial perfusion in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 2006, 47:565-572. 10.1016/j.jacc.2005.09.036, 16458137.
8. Fonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J 2007, 153:74-81.
9. Patsa C, Toutouzas K, Tsiamis E, Tsioufis C, Spanos A, Karanasos A, Michelongona A, Tousoulis D, Stefanadis C. Impact of metabolic syndrome on clinical outcomes after new generation drug-eluting stent implantation: The " obesity paradox" phenomenon is still apparent. Nutrition, metabolism, and cardiovascular diseases 2013 Apr, 23(4):307-313.
10. Pingitore A, Di Bella G, Lombardi M, Iervasi G, Strata E, Aquaro GD, Positano V, De Marchi D, Rossi G, L'Abbate A, Rovai D. The obesity paradox and myocardial infarct size. J Cardiovasc Med (Hagerstown) 2007, 8:713-717.
11. Fulop T, Jebelovszki E, Erdei N, Szerafin T, Forster T, Edes I, Koller A, Bagi Z. Adaptation of vasomotor function of human coronary arterioles to the simultaneous presence of obesity and hypertension. Arterioscler Thromb Vasc Biol 2007, 27:2348-2354. 10.1161/ATVBAHA.107.147991, 17823369.
12. Bagi Z, Feher A, Cassuto J. Microvascular responsiveness in obesity: implications for therapeutic intervention. Br J Pharmacol 2012, 165:544-560. 10.1111/j.1476-5381.2011.01606.x, 3315030, 21797844.
13. Bagi Z. Mechanisms of coronary microvascular adaptation to obesity. Am J Physiol Regul Integr Comp Physiol 2009, 297:R556-R567. 10.1152/ajpregu.90817.2008, 19535672.
14. Miura H, Liu Y, Gutterman DD. Human coronary arteriolar dilation to bradykinin depends on membrane hyperpolarization: contribution of nitric oxide and Ca2+-activated K+ channels. Circulation 1999, 99:3132-3138. 10.1161/01.CIR.99.24.3132, 10377076.
15. Faul F, Erdfelder E, Lang A-G, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007, 39:175-191. 10.3758/BF03193146, 17695343.
16. Fleischmann E, Teal N, Dudley J, May W, Bower JD, Salahudeen AK. Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int 1999, 55:1560-1567. 10.1046/j.1523-1755.1999.00389.x, 10201023.
17. Lainscak M, Haehling S, Doehner W, Anker SD. The obesity paradox in chronic disease: facts and numbers. J Cachex Sarcopenia Muscle 2012, 3:1-4.
18. Pries AR, Habazettl H, Ambrosio G, Hansen PR, Kaski JC, Schächinger V, Tillmanns H, Vassalli G, Tritto I, Weis M, de Wit C, Bugiardini R. A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings. Cardiovasc Res 2008, 80:165-174. 10.1093/cvr/cvn136, 18511433.
19. van Straten AHM, Bramer S, Soliman Hamad MA, van Zundert AAJ, Martens EJ, Schönberger JPAM, de Wolf AM. Effect of body mass index on early and late mortality after coronary artery bypass grafting. Ann Thorac Surg 2010, 89:30-37. 10.1016/j.athoracsur.2009.09.050, 20103201.
20. Vaduganathan M, Stone NJ, Lee R, McGee EC, Malaisrie SC, Silverberg RA, Kansal P, McCarthy PM. Perioperative statin therapy reduces mortality in normolipidemic patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2010, 140:1018-1027. 10.1016/j.jtcvs.2010.08.002, 20851427.
21. Vaduganathan M, Stone NJ, Andrei A-C, Lee R, Kansal P, Silverberg RA, Bonow RO, McCarthy PM. Midterm benefits of preoperative statin therapy in patients undergoing isolated valve surgery. Ann Thorac Surg 2012, 93:1881-1887. 10.1016/j.athoracsur.2012.02.091, 22632489.
22. Antoniades C, Demosthenous M, Reilly S, Margaritis M, Zhang M-H, Antonopoulos A, Marinou K, Nahar K, Jayaram R, Tousoulis D, Bakogiannis C, Sayeed R, Triantafyllou C, Koumallos N, Psarros C, Miliou A, Stefanadis C, Channon KM, Casadei B. Myocardial redox state predicts in-hospital clinical outcome after cardiac surgery effects of short-term pre-operative statin treatment. J Am Coll Cardiol 2012, 59:60-70. 10.1016/j.jacc.2011.08.062, 22192670.
23. Antoniades C, Bakogiannis C, Tousoulis D, Reilly S, Zhang M-H, Paschalis A, Antonopoulos AS, Demosthenous M, Miliou A, Psarros C, Marinou K, Sfyras N, Economopoulos G, Casadei B, Channon KM, Stefanadis C. Preoperative atorvastatin treatment in CABG patients rapidly improves vein graft redox state by inhibition of Rac1 and NADPH-oxidase activity. Circulation 2010, 122:S66-S73. 10.1161/CIRCULATIONAHA.109.927376, 20837928.
24. Brunner H, Gavras H. Commontary: Angiotensin blockade for hypertension: a promise fulfilled. Lancet 2002, 359:990-992. 10.1016/S0140-6736(02)08062-5, 11937175.
25. Oltman C, Davidson E, Coppey L, Kleinschmidt T, Lund D, Yorek M. Attenuation of vascular/neural dysfunction in zucker rats treated with enalapril or rotuvastatin. Obesity 2008, 16:82-89. 10.1038/oby.2007.19, 18223617.
26. Nawano M, Anai M, Funaki M, Kobayashi H, Kanda A, Fukushima Y, Inukai K, Ogilhara T, Sakado H, Onishi Y, Kikuchi M, Yazaki Y, Oka Y, Asano T. Imidapril, an angiotensin-converting enzyme inhibitor, improves insulin sensitivity by enhancing signal transduction via insulin receptor substrate proteins and improving vascular resistance in the zucker fatty rat. Metabolism 1999, 48:1248-1255. 10.1016/S0026-0495(99)90263-9, 10535386.
27. Bandeali S, Kayani W, Lee V, Pan W, Elayda M, Nambi V, Jneid H, Alam M, Wilson J, Birnbaum Y, Ballantye C, Virani S. Outcomes of preoperative angiotensin converting enzyme inhibitor therapy in patients undergoing isolated coronary artery bypass grafting. Am J Cardiol 2012, 110(7):919-923. 10.1016/j.amjcard.2012.05.021, 22727178.